Vincent LoPriore
Vermögen: 3 Mio $ am 30.06.2026
Vermögen: 3 Mio $ am 30.06.2026
Vincent S.
LoPriore is the founder of Gravitas Capital Partners LLC, founded in 2010, where the title held is Managing Partner.
Current jobs include Executive Chairman at Hepion Pharmaceuticals, Inc. starting in 2026, and Director at Canton Strategic Holdings, Inc. starting in 2025.
Former jobs include Chief Executive Officer & Director at Pinkbrick Holdings, Inc. from 2014 to 2015, and Advisor at Bishop Rosen & Co., Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.06.2026 | 944.420 ( 1,22 % ) | 3 Mio $ | 30.06.2026 | |
HEPION PHARMACEUTICALS, INC. 21,46 % | 28.04.2026 | 6.250.000 ( 21,46 % ) | 425 000 $ | 30.06.2026 |
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing -.--% | 23.02.2017 | 300.000 ( -.--% ) | - $ | Heute |
| Unternehmen | Position | Beginn |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Direktor/Vorstandsmitglied | 05.02.2026 |
| HEPION PHARMACEUTICALS, INC. | Vorsitzender | 16.03.2026 |
Gravitas Capital Partners LLC | Gründer | 01.04.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing | Vorstandsvorsitzender | 11.07.2015 |
Bishop Rosen & Co., Inc.
Bishop Rosen & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Bishop Rosen & Co., Inc.
Bishop Rosen & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing | Finance |
Gravitas Capital Partners LLC | |
Tharimmune, Inc.
Tharimmune, Inc. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company that develops novel therapeutic candidates targeting ferroptosis | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen